about
Myosin VI is a mediator of the p53-dependent cell survival pathway.MicroRNAs for osteosarcoma in the mouse: a meta-analysisncRNA-regulated immune response and its role in inflammatory lung diseasesHigh mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserineThe ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosisThe code of non-coding RNAs in lung fibrosisPostexposure administration of a {beta}2-agonist decreases chlorine-induced airway hyperreactivity in miceModulation of SCF beta-TrCP-dependent I kappaB alpha ubiquitination by hydrogen peroxide.Inhibition of lung fluid clearance and epithelial Na+ channels by chlorine, hypochlorous acid, and chloramines.The human long noncoding RNA lnc-IL7R regulates the inflammatory responsemiR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosisThe receptor for urokinase regulates TLR2 mediated inflammatory responses in neutrophils.DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation.The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis.The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages.IL-13 induces YY1 through the AKT pathway in lung fibroblasts.Identification of a microRNA signature in renal fibrosis: role of miR-21.miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.Regulation of alveolar epithelial Na+ channels by ERK1/2 in chlorine-breathing mice.Noninvasive imaging of experimental lung fibrosis.Extracellular histones inhibit efferocytosis.miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.p53, a target of estrogen receptor (ER) α, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells.Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation.Regulation of the p53 transcriptional activity.MicroRNAs in immune response and macrophage polarization.miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signalingActivation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury.Potential role of high-mobility group box 1 in cystic fibrosis airway disease.Mechanosensing by the α6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis.Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury.Participation of the urokinase receptor in neutrophil efferocytosis.miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses.miR-125a-5p regulates differential activation of macrophages and inflammation.Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species.Participation of the receptor for advanced glycation end products in efferocytosis.Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary FibrosisIntracellular HMGB1 negatively regulates efferocytosismiR-34a Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence.Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.
P50
Q24306104-2B2A2F8E-E5C4-4217-841C-77D0E3D2059DQ28069353-2823225B-018F-48FD-8A29-1EB8FBB00607Q28082698-06B98F80-B478-4773-85DE-D8C3909CF8D1Q28118997-EA96292C-C697-46ED-BF61-42ABFB1FE019Q28206046-63F147CA-59BA-4546-8018-81660459F821Q28386827-E51D0E4C-8B64-4D65-AAC4-857EB11AE16BQ28390694-D6B81713-A94F-4FDA-8D57-B0918217DC51Q33594018-4427ABE6-378D-4A90-8A33-A32C36745F32Q33744651-19952793-BF99-4DC2-B929-728A52289035Q33934251-C83066B6-BB77-4130-AD7A-CFEF3860CD28Q34044475-E130D919-C851-471A-A31D-6F5F80C64FB3Q34048147-13480127-683D-464A-98E0-531E6D22E714Q34353609-3C245C17-5A4A-4AA3-916B-7DA91459CA49Q34769562-802865AA-5117-4AAB-BACE-24B5FBB1CC4DQ34801576-8007BF99-5355-4979-BA67-DD571E4C0EBBQ35182151-4DFBD83F-DC6A-4030-B1EF-A286C469F2CDQ35326035-799FD486-03C0-49C3-AD31-E185EC88BDB6Q35850316-55D83C6F-1C28-4C7E-8686-26633D30F781Q35889167-EC428930-9FD4-4314-B9BA-680EB1AF1F6FQ36049518-5EC49CF2-1211-469E-9425-70D64FA32DA7Q36130954-21F55F83-F19D-4A82-9550-E9BB142284BDQ36183735-47CF6B9D-80CD-4EE7-A5BF-4ACC8BA62C9CQ36216301-218E5295-EAE4-4C14-8363-1BCF6BC6578DQ36283317-512A434D-65EB-45D1-AA9A-17DBD902113AQ36313234-F2A67515-E827-4012-8979-CBAE39A682D3Q36547119-65B48F53-9FB0-469E-8323-6B6B254D49D4Q36761526-6209AD98-E939-4EDD-96BC-322589A929BCQ36877369-E472D4C7-E678-4AEC-A117-4493BFD8CDA9Q36935244-6B62ED89-0482-41D1-9F11-EB9EB8DF9BC5Q37191868-D5F5EE05-A112-42CD-9AA8-777DDB602B44Q37275496-A2EDCBB8-F79D-4C36-91FE-D9DE7FD3800CQ37275898-842CBECA-B2CF-433C-9D9F-F7BB6663382CQ37354185-2E4D3BC9-83DB-4E1E-B79D-AEA93F7A80D8Q37368700-D8FE6444-DD46-4180-A470-C6268F967FA8Q37415862-E113DEC5-5BE1-4B92-82B4-39336A2C2C74Q37638952-1F44DF2F-3843-4A66-A625-13BB2348C9C8Q38654419-B5B9AE19-7DE9-4710-ACB1-2D25B1336443Q38771390-766FED6C-BEE8-4688-8B47-E4A6FF9EAA7AQ39382230-66DB2446-DBAB-4DB4-B517-DCEE4E818C21Q39763520-4E29C6D0-7354-4244-A669-1EF1B806F687
P50
description
researcher ORCID: 0000-0003-2615-131X
@en
name
Gang Liu
@ast
Gang Liu
@en
Gang Liu
@es
Gang Liu
@nl
type
label
Gang Liu
@ast
Gang Liu
@en
Gang Liu
@es
Gang Liu
@nl
prefLabel
Gang Liu
@ast
Gang Liu
@en
Gang Liu
@es
Gang Liu
@nl
P106
P1153
56555403100
P31
P496
0000-0003-2615-131X